Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Pfizer says employee stole confidential COVID-19 vaccine documents 

By Brian Buntz | November 24, 2021

PfizerPfizer (NYSE:PFE) accused a former employee Chun Xiao (Sherry) Li of uploading 12,000 documents from a company-issued laptop to a personal Google Drive account and various personal devices.

In a complaint filed in the U.S. District Court for the Southern District of California, Pfizer also accuses Li of misleading the company about what she did with the files she reportedly took, which included sensitive intellectual property.

The alleged stolen documents pertain to “numerous Pfizer vaccines, drugs, and other innovations,” including its COVID-19 vaccine and avelumab and elranatamab monoclonal antibodies.

The company jointly developed the COVID-19 vaccine with BioNTech. Pfizer jointly developed avelumab (Bavencio) with Merck KGaA, Darmstadt, Germany. The drug won FDA approval in 2020.

The bispecific monoclonal antibody elranatamab remains in the clinic.

The lawsuit notes that Pfizer invested more than $2 billion in the COVID-19 vaccine.

Pfizer believes that Li was planning to work for the competitor Xencor (NSDQ:XNCR), a clinical-stage biopharma based in Monrovia, California.

Li informed Pfizer that she planned to resign effective November 24, 2021.

Furthermore the company suspects that someone else is now in possession of the 12,000 documents. The lawsuit uses the fictitious names “Does 1 through 5” to refer to individuals who collaborated

Pfizer accuses Li of misappropriation of trade secrets, breach of contract, conversion and trespass to chattel.

The complaint also is seeking a court order to gain access to Li’s personal Google Drive account.

Li did not immediately respond to a request for comment.

Li joined Pfizer in 2006 as a Chinese employee. In 2016, she transferred to the company’s facility in La Jolla, near San Diego, California.

The company believes she downloaded thousands of sensitive files between October 23 to October 26, 2021.

The company believes she downloaded sensitive files between October 23 to October 26, 2021 after performing a forensic analysis of Li’s computing devices.

Intellectual property protection has emerged as a sensitive topic. Recently, 15 organizations including Public Citizen, Human Rights Watch and Doctors Without Borders co-signed a letter to the White House asking for an intellectual property waiver for COVID-19 vaccines to bolster international supply. In addition, more than 60 developing nations including South Africa and India have asked for such a waiver pertaining to COVID-19 vaccines, tests and treatments.

The case is titled Pfizer Inc. v. Li, S.D. Cal., No. 3:21-cv-01980.


Filed Under: Drug Discovery, Drug Discovery and Development, Infectious Disease
Tagged With: avelumab, COVID-19 vaccine, elranatamab, Pfizer
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE